BSE filing, NSE: ADITYA. Summary written from the filing by ALFA Finder's alert engine.
Aditya Ispat Ltd: key numbers
- Share price
- ₹8.75
- Market cap
- ₹4.68 Cr
- Revenue (annual)
- ₹32.78 Cr
- Net profit (annual)
- ₹-8.58 Cr
- P/E (TTM)
- -0.6×Sector 16.9×
- Promoter holding
- 24.32%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aditya Ispat Ltd
All →Aditya Ispat Annual General Meeting
Aditya Ispat Ltd concluded its 35th Annual General Meeting on September 30, 2026. Business included financial statement adoption, director reappointments, and a proposed capital reduction scheme.
Aditya Ispat Capital Structure Change
Aditya Ispat proposed a scheme to cancel 50,82,500 shares pro-rata, reducing paid-up capital to ₹0.27 Crore. No consideration is payable to shareholders for the cancelled shares.
Aditya Ispat Annual Report
Aditya Ispat Ltd has filed its 35th Annual Report for the financial year ended March 31, 2026, with the stock exchange.
Aditya Ispat Annual General Meeting
Aditya Ispat Ltd has issued a notice for its 35th AGM to be held on September 30, 2026, which includes a proposed scheme of capital reduction.
Aditya Ispat Board Meeting Outcome
The Board approved the 35th AGM notice and new director appointments. They also proposed a scheme for capital reduction to set off accumulated losses.
Aditya Ispat Board Meeting Date
Aditya Ispat Ltd has scheduled a board meeting on September 8, 2026. The board will finalize AGM details and consider a capital reorganization scheme.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.